These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10830228)

  • 1. Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines.
    Zuckermann AO; Grimm M; Czerny M; Ofner P; Ullrich R; Ploner M; Wolner E; Laufer G
    Transplantation; 2000 May; 69(9):1890-8. PubMed ID: 10830228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation.
    Carrier M; White M; Perrault LP; Pelletier GB; Pellerin M; Robitaille D; Pelletier LC
    J Heart Lung Transplant; 1999 Dec; 18(12):1218-23. PubMed ID: 10612381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D
    J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit antithymocyte globulin. A 10-year experience in cardiac transplantation.
    Copeland JG; Icenogle TB; Williams RJ; Rosado LJ; Butman SM; Vasu MA; Sethi GK; McDonald AN; Klees E; Rhenman MJ
    J Thorac Cardiovasc Surg; 1990 May; 99(5):852-60. PubMed ID: 2329823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring.
    Djamali A; Turc-Baron C; Portales P; Leverson G; Chong G; Clot J; Mourad G
    Transplantation; 2000 Mar; 69(5):799-805. PubMed ID: 10755529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithymocyte globulin induction therapy adjusted for immunologic risk after heart transplantation.
    Czer LS; Phan A; Ruzza A; Rafiei M; Setareh-Shenas S; Caceres M; Awad M; Soliman C; Mirocha J; De Robertis M; Kass RM; Trento A
    Transplant Proc; 2013; 45(6):2393-8. PubMed ID: 23953554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of anti-thymocyte globulin plasma levels on outcome parameters in stem cell transplanted children.
    Vogelsang V; Kruchen A; Wustrau K; Spohn M; Müller I
    Int Immunopharmacol; 2020 Jun; 83():106371. PubMed ID: 32197227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: a retrospective cohort study.
    Chen GD; Lai XQ; Ko DS; Qiu J; Wang CX; Han M; Li J; Huang G; He XS; Chen LZ
    Nephrology (Carlton); 2015 Aug; 20(8):539-43. PubMed ID: 25808082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midterm results of a prospective randomized comparison of two different rabbit-antithymocyte globulin induction therapies after heart transplantation.
    De Santo LS; Della Corte A; Romano G; Amarelli C; Onorati F; Torella M; De Feo M; Marra C; Maiello C; Giannolo B; Casillo R; Ragone E; Grimaldi M; Utili R; Cotrufo M
    Transplant Proc; 2004 Apr; 36(3):631-7. PubMed ID: 15110616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD; Flemming C
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
    Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG
    J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
    Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
    J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction Therapy With Antithymocyte Globulin in Patients Undergoing Cardiac Transplantation Is Associated With Decreased Coronary Plaque Progression as Assessed by Intravascular Ultrasound.
    Azarbal B; Cheng R; Vanichsarn C; Patel JK; Czer LS; Chang DH; Kittleson MM; Kobashigawa JA
    Circ Heart Fail; 2016 Jan; 9(1):e002252. PubMed ID: 26747860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low-dose antithymocyte globulins in kidney transplantation: results of a protocol of intermittent administration].
    Mourad G; Portales P; Garrigue V; Djamali A; Bouloux C; Chong G; Clot J
    Nephrologie; 2000; 21(5):253-8. PubMed ID: 11068775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithymocyte globulin induction therapy and myocardial complement deposition in pediatric heart transplantation.
    Ghaleb S; Wittekind SG; Martinez H; Kasten J; Gao Z; Hengehold T; Chin C
    Pediatr Transplant; 2021 Sep; 25(6):e13998. PubMed ID: 33704881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
    J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression induction with rabbit antithymocyte globulin in heart transplantation patients: 6-year experience at the Sheba Medical Center.
    Lavee J; Bar-Zohar D; Har-Zahav Y; Freimark D; Casif Y; Shinfeld A; Smolinsky AK
    Transplant Proc; 2000 Jun; 32(4):737-9. PubMed ID: 10856565
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.
    Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R
    Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
    Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
    Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved long-term survival after intra-operative single high-dose ATG-Fresenius induction in renal transplantation: a single centre experience.
    Kaden J; May G; Völp A; Wesslau C
    Ann Transplant; 2009; 14(3):7-17. PubMed ID: 19644154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.